Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection <italic toggle="yes">In Vivo</italic>
ABSTRACT Yellow fever virus (YFV) is an arthropod-borne flavivirus, infecting ~200,000 people worldwide annually and causing about 30,000 deaths. The live attenuated vaccine strain, YFV-17D, has significantly contributed in controlling the global burden of yellow fever worldwide. However, the viral...
Guardado en:
Autores principales: | Florian Douam, Yentli E. Soto Albrecht, Gabriela Hrebikova, Evita Sadimin, Christian Davidson, Sergei V. Kotenko, Alexander Ploss |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aa6cbfd3115148669213476b7fd1f49f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chimeric Vaccines Based on Novel Insect-Specific Flaviviruses
por: Jessica J. Harrison, et al.
Publicado: (2021) -
Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex
por: Emily H. Davis, et al.
Publicado: (2019) -
A Sensitive Yellow Fever Virus Entry Reporter Identifies Valosin-Containing Protein (VCP/p97) as an Essential Host Factor for Flavivirus Uncoating
por: Harish N. Ramanathan, et al.
Publicado: (2020) -
Experimental Adaptation of the Yellow Fever Virus to the Mosquito Aedes albopictus and Potential risk of urban epidemics in Brazil, South America
por: Fadila Amraoui, et al.
Publicado: (2018) -
Interleukin-1β Signaling in Dendritic Cells Induces Antiviral Interferon Responses
por: Lauren D. Aarreberg, et al.
Publicado: (2018)